Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,209,487 papers from all fields of science
Search
Sign In
Create Free Account
DCK gene
Known as:
DCK
, DEOXYCYTIDINE KINASE
, Deoxycytidine Kinase Gene
This gene is involved in deoxyribonucleoside phosphorylation.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Deoxycytidine Kinase
Drug Efflux
Drug resistance
Leukemia, Myelocytic, Acute
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Nonenantioselectivity property of human deoxycytidine kinase explained by structures of the enzyme in complex with L- and D-nucleosides.
E. Sabini
,
Saugata Hazra
,
M. Konrad
,
A. Lavie
Journal of Medicinal Chemistry
2007
Corpus ID: 22299249
Biological molecules are predominantly enantioselective. Yet currently two nucleoside analogue prodrugs (3TC and FTC) with…
Expand
Highly Cited
2003
Highly Cited
2003
Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance.
E. Månsson
,
Emma Flordal
,
+5 authors
F. Albertioni
Biochemical Pharmacology
2003
Corpus ID: 23807643
2002
2002
Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines.
C. van Bree
,
N. Castro Kreder
,
W. Loves
,
N. A. Franken
,
G. Peters
,
J. Haveman
International Journal of Radiation Oncology…
2002
Corpus ID: 6457215
Highly Cited
1999
Highly Cited
1999
Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562
C. Dumontet
,
K. Fabianowska-Majewska
,
+12 authors
J. Mackey
British Journal of Haematology
1999
Corpus ID: 26515296
Resistant variants of the human leukaemic line K562 were developed using selection with the deoxynucleoside analogues cytosine…
Expand
Review
1994
Review
1994
Properties and levels of deoxynucleoside kinases in normal and tumor cells; implications for chemotherapy.
S. Eriksson
,
Elias S. J. Arnér
,
+6 authors
J. Liliemark
Advances in Enzyme Regulation
1994
Corpus ID: 23820753
Highly Cited
1989
Highly Cited
1989
Kinetic properties and inhibition of human T lymphoblast deoxycytidine kinase.
N. Datta
,
D. Shewach
,
B. Mitchell
,
I. Fox
Journal of Biological Chemistry
1989
Corpus ID: 23669547
Highly Cited
1989
Highly Cited
1989
Human T-lymphoblast deoxycytidine kinase: purification and properties.
N. Datta
,
D. Shewach
,
M. Hurley
,
B. Mitchell
,
I. Fox
Biochemistry
1989
Corpus ID: 27800981
Previous observations present tremendous variations in the properties of deoxycytidine kinase. To clarify the properties and…
Expand
1989
1989
Human deoxycytidine kinase: kinetic mechanism and end product regulation.
M. Kim
,
D. H. Ives
Biochemistry
1989
Corpus ID: 39207783
The kinetic properties of the monomeric deoxycytidine kinase (EC 2.7.1.74) from leukemic human T-lymphoblasts have been…
Expand
Highly Cited
1981
Highly Cited
1981
Identification of the mechanism of activation of 9-beta-D-arabinofuranosyladenine in human lymphoid cells using mutants deficient in nucleoside kinases.
V. Verhoef
,
J. Sarup
,
A. Fridland
Cancer Research
1981
Corpus ID: 25611729
The biochemical basis of cellular resistance to 9-beta-D-arabinofuranosyladenine (ara-A) and its natural purine derivative…
Expand
Highly Cited
1981
Highly Cited
1981
A biochemical genetic study of the role of specific nucleoside kinases in deoxyadenosine phosphorylation by cultured human cells.
B. Ullman
,
B. Levinson
,
M. Hershfield
,
D. Martin
Journal of Biological Chemistry
1981
Corpus ID: 12245452
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE